These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 9360661

  • 1. The efficiency of fractionated parenteral iron treatment in CAPD patients.
    Akcicek F, Ozkahya M, Cirit M, Ok E, Unsal A, Toz H, Celik A, Atabay G, Basci A.
    Adv Perit Dial; 1997; 13():109-12. PubMed ID: 9360661
    [Abstract] [Full Text] [Related]

  • 2. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
    Silverberg DS, Blum M, Agbaria Z, Deutsch V, Irony M, Schwartz D, Baruch R, Yachnin T, Steinbruch S, Iaina A.
    Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
    [Abstract] [Full Text] [Related]

  • 3. Once weekly versus twice weekly subcutaneous administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Lui SF, Law CB, Ting SM, Li P, Lai KN.
    Clin Nephrol; 1991 Nov; 36(5):246-51. PubMed ID: 1752075
    [Abstract] [Full Text] [Related]

  • 4. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Li H, Wang SX.
    Blood Purif; 2008 Nov; 26(2):151-6. PubMed ID: 18212498
    [Abstract] [Full Text] [Related]

  • 5. Improved response to erythropoietin in peritoneal dialysis patients as compared to hemodialysis patients: role of iron deficiency.
    Raja R, Bloom E, Johnson R, Goldstein M.
    Adv Perit Dial; 1994 Nov; 10():135-8. PubMed ID: 7999811
    [Abstract] [Full Text] [Related]

  • 6. Use of bolus intraperitoneal iron dextran in continuous ambulatory peritoneal dialysis or continuous cyclic peritoneal dialysis patients receiving recombinant human erythropoietin.
    Mars RL, Moles K, Pope K, Hargrove P.
    Adv Perit Dial; 1999 Nov; 15():60-4. PubMed ID: 10682073
    [Abstract] [Full Text] [Related]

  • 7. Infusion of total dose iron versus oral iron supplementation in ambulatory peritoneal dialysis patients: a prospective, cross-over trial.
    Ahsan N.
    Adv Perit Dial; 2000 Nov; 16():80-4. PubMed ID: 11045266
    [Abstract] [Full Text] [Related]

  • 8. The evaluation of postdialysis L-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients.
    Kadiroglu AK, Yilmaz ME, Sit D, Kara IH, Isikoglu B.
    Ren Fail; 2005 Nov; 27(4):367-72. PubMed ID: 16060121
    [Abstract] [Full Text] [Related]

  • 9. ITDI is the preferred treatment for iron supplementation in rHuEpo-treated anemic PD patients.
    Ahsan N.
    Adv Perit Dial; 1998 Nov; 14():228-31. PubMed ID: 10649730
    [Abstract] [Full Text] [Related]

  • 10. [Single weekly dose of recombinant erythropoietin in children with chronic renal insufficiency].
    Guízar JM, Gutiérrez MJ, Sánchez G, Kornhauser C.
    Rev Invest Clin; 1996 Nov; 48(3):173-7. PubMed ID: 8966377
    [Abstract] [Full Text] [Related]

  • 11. [Clinical and economic significance of iron replacement in anemia treated with recombinant human erythropoietin in patients on hemodialysis].
    Vanková S, Safárová R, Horácková M, Herink J, Rychlík I, Bahbouh R, Půtová I.
    Cas Lek Cesk; 2001 Apr 12; 140(7):209-13. PubMed ID: 11374225
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of bolus intravenous iron dextran treatment in peritoneal dialysis patients receiving recombinant human erythropoietin.
    Ahsan N, Groff JA, Waybill MA.
    Adv Perit Dial; 1996 Apr 12; 12():161-6. PubMed ID: 8865893
    [Abstract] [Full Text] [Related]

  • 13. Safety of intravenous injection of iron saccharate in haemodialysis patients.
    Sunder-Plassmann G, Hörl WH.
    Nephrol Dial Transplant; 1996 Sep 12; 11(9):1797-802. PubMed ID: 8918625
    [Abstract] [Full Text] [Related]

  • 14. Comparative effects of erythropoietin with oral iron in peritoneal dialysis and hemodialysis patients.
    Raja R, Bloom E, Johnson R.
    Adv Perit Dial; 1993 Sep 12; 9():177-80. PubMed ID: 8105918
    [Abstract] [Full Text] [Related]

  • 15. Anemia of chronic renal failure: treatment with erythropoietin.
    Navarro M, Alonso A, Avilla JM, Espinosa L.
    Child Nephrol Urol; 1991 Sep 12; 11(3):146-51. PubMed ID: 1777893
    [Abstract] [Full Text] [Related]

  • 16. Intravenous iron in chronic kidney disease: haemoglobin change shortly after treatment of patients neither on dialysis nor on erythropoietin.
    Tagboto S, Cropper L, Mostafa S, Turner J, Bailey G, Pugh-Clarke K.
    J Ren Care; 2008 Sep 12; 34(3):112-5. PubMed ID: 18786076
    [Abstract] [Full Text] [Related]

  • 17. Once weekly subcutaneous erythropoietin is an effective maintenance therapy in the treatment of anemia of end stage renal disease in patients on CAPD.
    Saleh A, Krane NK, Caballero M, Starks E.
    Adv Perit Dial; 1991 Sep 12; 7():288-91. PubMed ID: 1680448
    [Abstract] [Full Text] [Related]

  • 18. Importance of iron saturation for erythropoietin responsiveness in chronic peritoneal dialysis.
    Jonnalagadda V, Bloom EJ, Raja RM.
    Adv Perit Dial; 1997 Sep 12; 13():113-5. PubMed ID: 9360662
    [Abstract] [Full Text] [Related]

  • 19. Subcutaneous recombinant human erythropoietin in patients on CAPD.
    Lye WC, Lee EJ.
    Adv Perit Dial; 1991 Sep 12; 7():285-7. PubMed ID: 1680447
    [Abstract] [Full Text] [Related]

  • 20. Erythropoietin requirements: a comparative multicenter study between peritoneal dialysis and hemodialysis.
    Coronel F, Herrero JA, Montenegro J, Fernandez C, Gandara A, Conesa J, Rivera MT, Torrente J, Portolés J, Gomez-Martino JR.
    J Nephrol; 2003 Sep 12; 16(5):697-702. PubMed ID: 14733416
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.